140 related articles for article (PubMed ID: 9127172)
1. Chemotherapy in advanced pancreatic cancer.
Dippold W; Bernhard H; Meyer zum Büschenfelde KH
Int J Pancreatol; 1997 Feb; 21(1):39-41. PubMed ID: 9127172
[TBL] [Abstract][Full Text] [Related]
2. Treatment of advanced pancreatic cancer with 5-fluorouracil, folinic acid and interferon alpha-2A: results of a phase II trial.
Bernhard H; Jäger-Arand E; Bernhard G; Heike M; Klein O; Riemann JF; Meyer zum Büschenfelde KH; Dippold W; Knuth A
Br J Cancer; 1995 Jan; 71(1):102-5. PubMed ID: 7819023
[TBL] [Abstract][Full Text] [Related]
3. Combination 5-fluorouracil (FU), folinic acid (FA), and alpha-interferon 2B in advanced gastric cancer: results of a phase II trial.
Jäger E; Bernhard H; Klein O; Wächter B; Theiss F; Dippold W; Meyer zum Büschenfelde KH; Knuth A
Ann Oncol; 1995 Feb; 6(2):153-6. PubMed ID: 7540418
[TBL] [Abstract][Full Text] [Related]
4. Combination fluorouracil, folinic acid, and interferon alfa-2a: an active regimen in advanced pancreatic carcinoma.
Knuth A; Bernhard H; Klein O; Meyer zum Büschenfelde KH
Semin Oncol; 1992 Apr; 19(2 Suppl 3):211-4. PubMed ID: 1557650
[TBL] [Abstract][Full Text] [Related]
5. Interferon-alpha does not improve the antineoplastic efficacy of high-dose infusional 5-fluorouracil plus folinic acid in advanced colorectal cancer. First results of a randomized multicenter study by the Association of Medical Oncology of the German Cancer Society (AIO).
Köhne CH; Wilke H; Hecker H; Schöffski P; Käufer C; Rauschecker H; Andreesen R; Ohl U; Lange HJ; Klaassen U
Ann Oncol; 1995 May; 6(5):461-6. PubMed ID: 7669711
[TBL] [Abstract][Full Text] [Related]
6. The use of chemotherapy in the treatment of advanced gastric and pancreas cancer.
Kelsen D
Semin Oncol; 1994 Aug; 21(4 Suppl 7):58-66. PubMed ID: 8091242
[TBL] [Abstract][Full Text] [Related]
7. Phase II trial of prolonged continuous infusion of 5-fluorouracil and interferon-alpha in patients with advanced pancreatic cancer. Eastern Cooperative Oncology Group Protocol 3292.
Sparano JA; Lipsitz S; Wadler S; Hansen R; Bushunow PW; Kirkwood J; Flynn PJ; Dutcher JP; Benson AB
Am J Clin Oncol; 1996 Dec; 19(6):546-51. PubMed ID: 8931668
[TBL] [Abstract][Full Text] [Related]
8. Combined epirubicin, 5-fluorouracil and folinic acid vs no treatment for patients with advanced pancreatic cancer: a prospective comparative study.
Tsavaris N; Tentas K; Tzivras M; Kosmas C; Kalachanis N; Katsikas M; Dimitrakopoulos A; Papastratis G; Macheras A; Karatzas G; Sechas M
J Chemother; 1998 Aug; 10(4):331-7. PubMed ID: 9720474
[TBL] [Abstract][Full Text] [Related]
9. Second-line treatment with high-dose 5-fluorouracil and folinic acid in advanced colorectal cancer refractory to standard-dose 5-fluorouracil treatment.
Jäger E; Klein O; Wächter B; Müller B; Braun U; Knuth A
Oncology; 1995; 52(6):470-3. PubMed ID: 7478433
[TBL] [Abstract][Full Text] [Related]
10. Weekly high-dose infusional 5-fluorouracil (HD-5-FU) combinations in the treatment of advanced breast cancer: results of phase I/II studies with weekly 24-hour infusion of HD-5-FU plus high-dose folinic acid (FA) alone and in combination with paclitaxel and cisplatin.
Klaassen U; Wilke H; Seeber S
J Infus Chemother; 1996; 6(3):127-32. PubMed ID: 9229323
[TBL] [Abstract][Full Text] [Related]
11. Weekly high-dose leucovorin versus low-dose leucovorin combined with fluorouracil in advanced colorectal cancer: results of a randomized multicenter trial. Study Group for Palliative Treatment of Metastatic Colorectal Cancer Study Protocol 1.
Jäger E; Heike M; Bernhard H; Klein O; Bernhard G; Lautz D; Michaelis J; Meyer zum Büschenfelde KH; Knuth A
J Clin Oncol; 1996 Aug; 14(8):2274-9. PubMed ID: 8708717
[TBL] [Abstract][Full Text] [Related]
12. Biochemical modulation of 5-fluorouracil by folinic acid or alpha-interferon with and without other cytostatic drugs in gastric, esophageal, and pancreatic cancer.
Wilke H; Stahl M; Schmoll HJ; Preusser P; Fink U; Meyer HJ; Achterrath W; Knipp H; Köhne-Wömpner CH; Harstrick A
Semin Oncol; 1992 Apr; 19(2 Suppl 3):215-9. PubMed ID: 1557651
[TBL] [Abstract][Full Text] [Related]
13. Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.).
Gebbia V; Majello E; Testa A; Pezzella G; Giuseppe S; Giotta F; Riccardi F; Fortunato S; Colucci G; Gebbia N
Cancer; 1996 Sep; 78(6):1300-7. PubMed ID: 8826954
[TBL] [Abstract][Full Text] [Related]
14. Weekly therapy with folinic acid (FA) and high-dose 5-fluorouracil (5-FU) 24-hour infusion in pretreated patients with metastatic colorectal carcinoma. A multicenter study by the Association of Medical Oncology of the German Cancer Society (AIO).
Weh HJ; Wilke HJ; Dierlamm J; Klaassen U; Siegmund R; Illiger HJ; Schalhorn A; Kreuser ED; Hilgenfeld U; Steinke B
Ann Oncol; 1994 Mar; 5(3):233-7. PubMed ID: 8186170
[TBL] [Abstract][Full Text] [Related]
15. Fluorouracil plus interferon + folinic acid in regional and systemic therapy in colorectal cancer.
Preiss J
Semin Oncol; 1992 Apr; 19(2 Suppl 3):220-4. PubMed ID: 1557652
[TBL] [Abstract][Full Text] [Related]
16. High-dose 5-fluorouracil / folinic acid in combination with three-weekly mitomycin C in the treatment of advanced gastric cancer. A phase II study.
Hofheinz RD; Hartung G; Samel S; Hochhaus A; Pichlmeier U; Post S; Hehlmann R; Queisser W
Onkologie; 2002 Jun; 25(3):255-60. PubMed ID: 12119460
[TBL] [Abstract][Full Text] [Related]
17. Phase II evaluation of fluorouracil and recombinant alpha-2a-interferon in previously untreated patients with pancreatic adenocarcinoma.
Pazdur R; Ajani JJ; Abbruzzese JL; Belt RJ; Dakhil SR; Dubovsky D; Graham S; Pilat S; Winn R; Levin B
Cancer; 1992 Oct; 70(8):2073-6. PubMed ID: 1394037
[TBL] [Abstract][Full Text] [Related]
18. Effects of 5-fluorouracil and leucovorin in the treatment of pancreatic-biliary tract adenocarcinomas.
Choi CW; Choi IK; Seo JH; Kim BS; Kim JS; Kim CD; Um SH; Kim JS; Kim YH
Am J Clin Oncol; 2000 Aug; 23(4):425-8. PubMed ID: 10955877
[TBL] [Abstract][Full Text] [Related]
19. Irinotecan combined with gemcitabine, 5-fluorouracil, leucovorin, and cisplatin (G-FLIP) is an effective and noncrossresistant treatment for chemotherapy refractory metastatic pancreatic cancer.
Kozuch P; Grossbard ML; Barzdins A; Araneo M; Robin A; Frager D; Homel P; Marino J; DeGregorio P; Bruckner HW
Oncologist; 2001; 6(6):488-95. PubMed ID: 11743211
[TBL] [Abstract][Full Text] [Related]
20. A phase II trial of gemcitabine in combination with 5-fluorouracil (24-hour) and folinic acid in patients with chemonaive advanced pancreatic cancer.
Oettle H; Arning M; Pelzer U; Arnold D; Stroszczynski C; Langrehr J; Reitzig P; Kindler M; Herrenberger J; Musch R; Korsten EW; Huhn D; Riess H
Ann Oncol; 2000 Oct; 11(10):1267-72. PubMed ID: 11106115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
